The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
The 2016 edition represents a revision of the prior classification rather than an entirely new classification and attempts to incorporate new clinical, prognostic, morphologic, immunophenotypic, and genetic data that have emerged since the last edition. The major changes in the classification and their rationale are presented here.
СЗО – 2016 – ревизия на класификацията на миелоидните левкемии и на острата левкоза